{"transactions":[{"id":1757462,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified stock option (Right to Buy)","published_at":"2023-10-19T21:01:13.000Z","date":"2023-10-17","kind":"exercise","planned":true,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on June 16, 2019, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. The stock options are also subject to accelerated vesting as set forth in the employment agreement between the Issuer and the Reporting Person."}],"balance_after":153473,"derivative":{"exercise_price":12.01,"expiration_date":"2028-06-15","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-23-053186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123053186/doc4.xml","form_type":"4"}},{"id":1757461,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-10-19T21:01:13.000Z","date":"2023-10-17","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":30,"value":210000.0,"ownership":{"direct":true},"balance_after":43210,"source":{"system":"sec-edgar","filing":"0001209191-23-053186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123053186/doc4.xml","form_type":"4"}},{"id":1757460,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-10-19T21:01:13.000Z","date":"2023-10-17","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":12.01,"value":84070.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 909 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":50210,"source":{"system":"sec-edgar","filing":"0001209191-23-053186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123053186/doc4.xml","form_type":"4"}},{"id":1946999,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:09:26.000Z","date":"2023-03-16","kind":"tax_withholding","acquired":false,"shares":1687,"price":17.12,"value":28881.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the vesting of Restricted Stock Units granted on February 28, 2022.  The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":42301,"source":{"system":"sec-edgar","filing":"0001209191-23-019770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123019770/doc4.xml","form_type":"4"}},{"id":1973501,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock (right to buy)","published_at":"2023-03-03T21:43:08.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 1, 2023."}],"balance_after":91000,"derivative":{"exercise_price":19.64,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001209191-23-015598","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123015598/doc4.xml","form_type":"4"}},{"id":1973500,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-03T21:43:08.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2024."}],"balance_after":43988,"source":{"system":"sec-edgar","filing":"0001209191-23-015598","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123015598/doc4.xml","form_type":"4"}},{"id":2043708,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-27T21:28:11.000Z","date":"2022-11-20","kind":"other","acquired":true,"shares":712,"price":11.02,"value":7846.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":24488,"source":{"system":"sec-edgar","filing":"0001209191-23-005254","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123005254/doc5.xml","form_type":"5"}},{"id":2043707,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-27T21:28:11.000Z","date":"2022-05-20","kind":"other","acquired":true,"shares":1215,"price":11.02,"value":13389.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":23776,"source":{"system":"sec-edgar","filing":"0001209191-23-005254","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123005254/doc5.xml","form_type":"5"}},{"id":2360745,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock (right to buy)","published_at":"2022-03-03T02:00:25.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":66500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 28, 2022."}],"balance_after":66500,"derivative":{"exercise_price":20.02,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":66500},"source":{"system":"sec-edgar","filing":"0001209191-22-015129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122015129/doc4.xml","form_type":"4"}},{"id":2360744,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-03T02:00:25.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2023."}],"balance_after":22561,"source":{"system":"sec-edgar","filing":"0001209191-22-015129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122015129/doc4.xml","form_type":"4"}},{"id":2428762,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified stock option (Right to Buy)","published_at":"2022-01-21T21:54:05.000Z","date":"2022-01-19","kind":"exercise","acquired":false,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock option granted June 16, 2018 with 25% vesting on the first anniversary of the grant date and the remainder vesting in a series of thirty-six (36) successive equal monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":160473,"derivative":{"exercise_price":12.01,"expiration_date":"2028-06-15","underlying":"Common stock","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0001209191-22-004453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122004453/doc4.xml","form_type":"4"}},{"id":2428761,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-21T21:54:05.000Z","date":"2022-01-19","kind":"sale","acquired":false,"shares":6700,"price":21.206,"value":142080.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $20.77 and $21.68. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":8311,"source":{"system":"sec-edgar","filing":"0001209191-22-004453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122004453/doc4.xml","form_type":"4"}},{"id":2428760,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-21T21:54:05.000Z","date":"2022-01-19","kind":"exercise","acquired":true,"shares":6700,"price":12.01,"value":80467.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,928 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":15011,"source":{"system":"sec-edgar","filing":"0001209191-22-004453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122004453/doc4.xml","form_type":"4"}},{"id":2820210,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T22:27:28.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 26, 2021."}],"balance_after":125000,"derivative":{"exercise_price":15.29,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-016288","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919121016288/doc4.xml","form_type":"4"}},{"id":2876647,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:46:07.000Z","date":"2020-11-20","kind":"other","acquired":true,"shares":277,"price":11.61,"value":3215.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":6383,"source":{"system":"sec-edgar","filing":"0001209191-21-008108","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919121008108/doc5.xml","form_type":"5"}},{"id":2876646,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-05T21:46:07.000Z","date":"2020-05-20","kind":"other","acquired":true,"shares":1165,"price":14.45,"value":16834.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":6106,"source":{"system":"sec-edgar","filing":"0001209191-21-008108","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919121008108/doc5.xml","form_type":"5"}},{"id":3246395,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-26T21:18:16.000Z","date":"2020-02-24","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 24, 2020."}],"balance_after":45000,"derivative":{"exercise_price":22.61,"expiration_date":"2030-02-23","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-20-012997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919120012997/doc4.xml","form_type":"4"}},{"id":3279684,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-11T21:06:47.000Z","date":"2019-05-20","kind":"other","acquired":true,"shares":1471,"price":14.45,"value":21255.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c)."}],"balance_after":4941,"source":{"system":"sec-edgar","filing":"0001209191-20-008272","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919120008272/doc5.xml","form_type":"5"}},{"id":3599367,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-12T22:42:52.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":56250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the Vesting Commencement Date of March 8, 2019."}],"balance_after":56250,"derivative":{"exercise_price":25.19,"expiration_date":"2029-03-07","underlying":"Common Stock","underlying_shares":56250},"source":{"system":"sec-edgar","filing":"0001209191-19-018982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919119018982/doc4.xml","form_type":"4"}},{"id":3663119,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-12T22:25:54.000Z","date":"2018-11-20","kind":"other","acquired":true,"shares":1470,"price":14.45,"value":21241.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c)."}],"balance_after":3470,"source":{"system":"sec-edgar","filing":"0000899243-19-003318","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000089924319003318/doc5.xml","form_type":"5"}},{"id":3863674,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":108883,"kind":"person","name":"Krasner Alan Seth","position":1,"cik":"0001435775","reported_name":"Krasner Alan Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-07-20T20:06:25.000Z","date":"2018-07-20","kind":"purchase","acquired":true,"shares":2000,"price":17,"value":34000.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000899243-18-020264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/doc4.xml","form_type":"4"}}]}